Literature DB >> 22394222

Withania somnifera chemotypes NMITLI 101R, NMITLI 118R, NMITLI 128R and withaferin A protect Mastomys coucha from Brugia malayi infection.

S Kushwaha1, V K Soni, P K Singh, N Bano, A Kumar, R S Sangwan, S Misra-Bhattacharya.   

Abstract

Withania somnifera is an ayurvedic Indian medicinal plant whose immunomodulatory activities have been widely used as a home remedy for several ailments. We recently observed immunostimulatory properties in the root extracts of chemotypes NMITLI-101, NMITLI-118, NMITLI-128 and pure withanolide, withaferin A. In the present study, we evaluated the potential immunoprophylactic efficacies of these extracts against an infective pathogen. Our results show that administration of aqueous ethanol extracts (10 mg/kg) and withaferin A (0·3 mg/kg), 7 days before and after challenge with human filarial parasite Brugia malayi, offers differential protection in Mastomys coucha with chemotype 101R offering best protection (53·57%) as compared to other chemotypes. Our findings also demonstrate that establishment of B. malayi larvae was adversely affected by pretreatment with withaferin A as evidenced by 63·6% reduction in adult worm establishment. Moreover, a large percentage of the established female worms (66·2%) also showed defective embryogenesis. While the filaria-specific immunological response induced by withaferin A and NMITLI-101 showed a mixed Th1/Th2 phenotype, 118R stimulated production of IFN-γ and 128R increased levels of IL-4. Taken together, our findings reveal potential immunoprophylactic properties of W. somnifera, and further studies are needed to ascertain the benefits of this plant against other pathogens as well.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22394222     DOI: 10.1111/j.1365-3024.2012.01352.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  9 in total

1.  Immunization of Mastomys coucha with Brugia malayi recombinant trehalose-6-phosphate phosphatase results in significant protection against homologous challenge infection.

Authors:  Susheela Kushwaha; Prashant Kumar Singh; Ajay Kumar Rana; Shailja Misra-Bhattacharya
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

2.  Alcoholic Fractions F5 and F6 from Withania somnifera Leaves Show a Potent Antileishmanial and Immunomodulatory Activities to Control Experimental Visceral Leishmaniasis.

Authors:  Sambamurthy Chandrasekaran; Jalaja Veronica; Shyam Sundar; Radheshyam Maurya
Journal:  Front Med (Lausanne)       Date:  2017-05-12

Review 3.  Withania somnifera (L.) Dunal (Ashwagandha) for the possible therapeutics and clinical management of SARS-CoV-2 infection: Plant-based drug discovery and targeted therapy.

Authors:  Manali Singh; Kuldeep Jayant; Dipti Singh; Shivani Bhutani; Nitesh Kumar Poddar; Anis Ahmad Chaudhary; Salah-Ud-Din Khan; Mohd Adnan; Arif Jamal Siddiqui; Md Imtaiyaz Hassan; Faez Iqbal Khan; Dakun Lai; Shahanavaj Khan
Journal:  Front Cell Infect Microbiol       Date:  2022-08-15       Impact factor: 6.073

4.  Natural products as a source for treating neglected parasitic diseases.

Authors:  Dieudonné Ndjonka; Ludmila Nakamura Rapado; Ariel M Silber; Eva Liebau; Carsten Wrenger
Journal:  Int J Mol Sci       Date:  2013-02-06       Impact factor: 5.923

5.  De novo assembly, functional annotation and comparative analysis of Withania somnifera leaf and root transcriptomes to identify putative genes involved in the withanolides biosynthesis.

Authors:  Parul Gupta; Ridhi Goel; Sumya Pathak; Apeksha Srivastava; Surya Pratap Singh; Rajender Singh Sangwan; Mehar Hasan Asif; Prabodh Kumar Trivedi
Journal:  PLoS One       Date:  2013-05-08       Impact factor: 3.240

6.  Tropine forming tropinone reductase gene from Withania somnifera (Ashwagandha): biochemical characteristics of the recombinant enzyme and novel physiological overtones of tissue-wide gene expression patterns.

Authors:  Amit Kumar Kushwaha; Neelam Singh Sangwan; Prabodh Kumar Trivedi; Arvind Singh Negi; Laxminarain Misra; Rajender Singh Sangwan
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

7.  Stability indicating studies on NMITLI 118RT+ (standardized extract of withania somnifera dunal).

Authors:  Hafsa Ahmad; Kiran Khandelwal; Shakti Deep Pachauri; Rajender Singh Sanghwan; Anil Kumar Dwivedi
Journal:  Pharmacogn Mag       Date:  2014-07       Impact factor: 1.085

8.  Immunogenicity and Protective Efficacy of Brugia malayi Heavy Chain Myosin as Homologous DNA, Protein and Heterologous DNA/Protein Prime Boost Vaccine in Rodent Model.

Authors:  Jyoti Gupta; Manisha Pathak; Sweta Misra; Shailja Misra-Bhattacharya
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

9.  Immunization with Brugia malayi Myosin as Heterologous DNA Prime Protein Boost Induces Protective Immunity against B. malayi Infection in Mastomys coucha.

Authors:  Jyoti Gupta; Sweta Misra; Shailja Misra-Bhattacharya
Journal:  PLoS One       Date:  2016-11-09       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.